VAXBRIEF

Category: VaxBrief Intelligence

  • Vax Brief 18th Feb 2026

    —

    by

    VaxBrief Editorial
    in ,

    Silence is the day’s dominant signal. The absence of US federal spring booster guidance is driving a high-risk, rapidly spreading narrative framing institutional inaction as deliberate concealment — while a resurgent trial-design absolutism narrative uses recent Therapeutic Goods Administration (TGA) methodological updates to argue that no current vaccine safety data is trustworthy.

  • Vax Brief 27th January 2026

    —

    by

    VaxBrief Editorial
    in ,

    Today’s surveillance identifies multiple active vaccine-related narratives linked to regulatory and policy shifts across the US and UK. The most prominent is a US transition of several routine pediatric vaccines to Shared Clinical Decision-Making, which is being interpreted as a structural change with potential implications for access and coverage. Concurrently, the UK’s loss of measles…

  • Daily Brief 23rd January 2026

    —

    by

    VaxBrief Editorial
    in ,

    Narrative surveillance for January 23 indicates continued circulation of three active vaccine-related narratives: claims of mRNA “bio-persistence” and neurological harm, renewed assertions that non-saline placebo trials are illegitimate, and local concern in New Zealand about vaccine procurement and perceived loss of choice. These narratives are spreading across social media, blogs, and local forums, with varying…

  • Daily Brief – Jan 21st 2026

    —

    by

    VaxBrief Editorial
    in , ,

    Data Window: January 21, 2026 (rolling 24-hour scan)Regions: United States · Canada · United Kingdom · Australia · New Zealand Summary Narratives in the past 24 hours centre on Scientific Decoupling following a U.S. HHS shift moving six childhood vaccines from Routine to Shared Clinical Decision-Making. Discussion focuses on perceived divergence from peer-country schedules and uncertainty about…

  • Daily Brief – January 20th 2026

    —

    by

    VaxBrief Editorial
    in ,

    The past 24 hours show increasing divergence between U.S. childhood immunisation policy and that of peer countries. While the UK, Australia, New Zealand, and Canada have expanded or maintained routine schedules, the U.S. Department of Health and Human Services has reduced its routine childhood schedule to 11 diseases, shifting several vaccines to Shared Clinical Decision-Making.…